Effect of vitamin c on the absorption of levothyroxine in patients with hypothyroidism and gastritis

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages

  Jubiz, William ^a   Ramirez, Marcela ^a  

^a UNIVERSIDAD LIBRE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GASTRITIS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; MIDDLE AGED; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; ASCORBIC ACID; FEMALE; GASTRITIS; HUMANS; HYPOTHYROIDISM; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84902353963     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4360     Document Type: Article

References (19)

1. Jubiz W. Tratamiento del hipotiroidismo. In: Endocrinología cl ínica. 6th ed. Cali, Colombia: Talleres de Litocencoa; 2012:139-141.
2. Jubiz W. Factores que afectan la absorción de levotiroxina. In: Endocrinología clínica. 6th ed. Cali, Colombia: Talleres de Litocencoa; 2012:770.
3. Fish LH,Schwartz HL,Cavanaugh J Replacement dose, metabolism, and bioavailability of levothyroxine in th e treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans N Engl J Med. 1987 316 764-770.
4. Eledrisi MS, Szymajda A, Alshanti M, Urban RJ. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine. South Med J. 2001;94:833-836.
5. Pabla D, Akhlaghi F, Zia, H. A comparative pH-dissolution profile study of selected commercial levothyroxine produ cts using inductively couple plasma mass spectrometry. Eur J Pharm Biopharm. 2008;10:193-197.
6. Sherman SI, Malecha SE. Absorption and malabsorption of levothyroxine sodium. Am J Ther. 1995;2:814-818.
7. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, Annibale B. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:17 87-1795.
8. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492-502.
9. McDermott MT, Ridgway EC. Thyr oid hormone resistance syndromes. Am J Med. 1993;94:424-432.
10. Shapiro LE, Sievert R. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab. 1997;82:2592-2595.
11. Mercuro G, Panzuto MG, Bina A, et al. Cardiac function, physical exercise capacity and quality of life during long-term thyrotropin suppressive therapy with levothyroxine: Effect of individual dose tailoring. J Clin Endocrinol Metab. 2000;85:159-164.
12. Antú nez PB, Licht SD. VitaminCimproves the apparent absorption of levothyroxine in a subset of patients receiving this hormone for primary hypothyroidism. Rev Argent Endocrinol Metab. 2011;48: 16-24.
13. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860.
14. Skikne BS, Lynch SR, Cook JD. Role of gastric acid in food iron absorption. Gastroenterology. 1981;81:1068-1071.
15. Lombard M, Chua E, O'Toole P. Regulation of intestinal non-haem iron absorption. Gut. 1997;40:435-439.
16. Schade SG, Cohen RJ, Conrad ME. Effect of hydrochloric acid on iron absorption. N Engl J Med. 1968;279:672-674.
17. Bernareggi A, Grata E, Pinorini MT, Conti A. Oral liquid formulation of levothyroxine is stable in breakfast beverages and may improve thyroid patient c ompliance. Pharmaceutics. 2013;5:621-633.
18. Vita R, Benvenga S. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitors: a problem that was solved by switching to L-T4 in soft gel capsule. Endocr Pract. 2013:1-11.
19. Pirola I, Formenti AM, Gandossi E, et al. Oral liquid L-thyroxine (L-T4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes S urg. 2013;23:1493-1496.